Kaufman, Marc J.
Harvard University · McLean Hospital
6 papers on CoChatORCID 0000-0002-4383-1264
Most cited papers
- Verified
Brain Reactivity to Smoking Cues Prior to Smoking Cessation Predicts Ability to Maintain Tobacco Abstinence
Janes, A. C., Pizzagalli, D. A., Richardt, S., Frederick, B. D., Chuzi, S., Pachas, G., Culhane, M. A., Holmes, A. J., Fava, M., Evins, A. E., et al. (2010) · Biological Psychiatry
Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes
Cited by 416
- Verified
Prefrontal and temporal gray matter density decreases in opiate dependence
Lyoo, I. K., Pollack, M. H., Silveri, M. M., Ahn, K. H., Diaz, C. I., Hwang, J., Kim, S. J., Yurgelun-Todd, D. A., Kaufman, M. J., & Renshaw, P. F. (2006) · Psychopharmacology
Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes
Cited by 178
- Verified
A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus
Ekhtiari, H., Zare-Bidoky, M., Sangchooli, A., Janes, A. C., Kaufman, M. J., Oliver, J. A., Prisciandaro, J. J., Wüstenberg, T., Anton, R. F., Bach, P., et al. (2022) · Nature Protocols
Substance Abuse Treatment and OutcomesNeural and Behavioral Psychology Studies
Cited by 89
- Verified
Brain Kinetics of Paroxetine and Fluoxetine on the Third Day of Placebo Substitution: A Fluorine MRS Study
Henry, M. E., Moore, C. M., Kaufman, M. J., Michelson, D., Schmidt, M. E., Stoddard, E., Vuckevic, A. J., Berreira, P. J., Cohen, B. M., & Renshaw, P. F. (2000) · American Journal of Psychiatry
Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior
Cited by 61
- Verified
Clathrin-nanoparticles deliver BDNF to hippocampus and enhance neurogenesis, synaptogenesis and cognition in HIV/neuroAIDS mouse model
Vitaliano, G. D., Kim, J. K., Kaufman, M. J., Adam, C. W., Zeballos, G., Shanmugavadivu, A., Subburaju, S., McLaughlin, J. P., Lukas, S. E., & Vitaliano, F. (2022) · Communications Biology
Nanoparticle-Based Drug DeliveryBarrier Structure and Function Studies
Cited by 48
- Verified
L-368,899, a potent orally active oxytocin antagonist for potential use in preterm labor
Pettibone, D. J., Clineschmidt, B. V., Guidotti, M. T., Lis, E. V., Reiss, D. R., Woyden, C. J., Bock, M. G., Evans, B. E., Freidinger, R. M., Hobbs, D. W., et al. (1993) · Drug Development Research
Neuroendocrine regulation and behaviorPreterm Birth and Chorioamnionitis
Cited by 43
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free